Krka, d. d.

Warsaw Stock Exchange KRK.WA

Krka, d. d. Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -378.85 M

Krka, d. d. Net Cash Used For Investing Activities is USD -378.85 M for the year ending December 31, 2023, a -563.37% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Krka, d. d. Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD 81.76 M, a 119.27% change year over year.
  • Krka, d. d. Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -424.19 M, a -216.85% change year over year.
  • Krka, d. d. Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD -133.88 M, a 4.42% change year over year.
  • Krka, d. d. Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD -140.06 M, a -7.02% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
Warsaw Stock Exchange: KRK.WA

Krka, d. d.

CEO Dr. Jože Colaric
IPO Date April 11, 2012
Location Slovenia
Headquarters Šmarješka cesta 6
Employees 12,675
Sector Health Care
Industries
Description

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular diseases; the gastrointestinal tract; central nervous system; pain relief; anti-infectives; blood and blood-forming organs; urological; diabetes; and oncology. The company also provides non-prescription products, such as products for oral cavity and pharynx; cough and cold products; analgesics; nasal products; vitamin and mineral products; products for enhancing cerebral and peripheral circulation; products for enhancing digestive tract and digestion; health care products; and others. In addition, it offers animal health products comprising antiinfectives, antiparasitics, and other products for farm and companion animals. Further, the company provides health resort and tourist services. Krka, d. d. was founded in 1954 and is headquartered in Novo Mesto, Slovenia.

Similar companies

TOA.WA

TOYA S.A.

USD 1.75

1.58%

ASB.WA

ASBISc Enterprises Plc

USD 4.27

0.06%

ATD.WA

Atende S.A.

USD 0.61

-0.43%

GPW.WA

Gielda Papierów Wartosciowych w Warszawie S.A.

USD 9.80

-0.12%

KTY.WA

Grupa Kety S.A.

USD 165.64

1.04%

StockViz Staff

January 15, 2025

Any question? Send us an email